Deep imaging for visualizing nitric oxide in lipid droplets: discovering the relationship between nitric oxide and

Miantai Ye1, Wei Hu, Meng He

  • 1Key Laboratory of Analytical Chemistry of the State Ethnic Affairs Commission, College of Chemistry and Material Science, South-central University for Nationalities, Wuhan 430074, China. zhjminda@mail.scuec.edu.cn lichychem@mail.scuec.edu.cn.

Chemical Communications (Cambridge, England)
|May 7, 2020
PubMed

Insights

Researchers developed a new fluorescent probe to detect nitric oxide (NO) in lipid droplets. This finding links NO production to drug resistance, suggesting NO inhibitors can enhance cancer therapy effectiveness.

Area of Science:

  • Chemical Biology
  • Biomedical Imaging
  • Cancer Research

Background:

  • Nitric oxide (NO) plays a complex role in cellular processes, including cancer.
  • Lipid droplets are increasingly recognized as key players in cancer progression and drug resistance.
  • Selective detection of NO within specific cellular compartments like lipid droplets is challenging.

Purpose of the Study:

  • To develop a novel near-infrared two-photon fluorescent probe for selective NO detection.
  • To visualize and quantify NO levels within lipid droplets in live cells.
  • To investigate the correlation between NO production in lipid droplets and resistance to anti-tumor drugs.

Main Methods:

  • Synthesis of a novel near-infrared two-photon fluorescent probe, termed TAN.
  • Application of the TAN probe for selective detection and deep-depth imaging of NO in lipid droplets.
  • Evaluation of the impact of NO inhibition on the efficacy of chemotherapeutic agents in cancer cells.

Main Results:

  • The TAN probe demonstrated high selectivity and sensitivity for NO detection in lipid droplets.
  • Deep-depth imaging revealed significant NO production within lipid droplets of drug-resistant cancer cells.
  • Inhibition of NO production in lipid droplets significantly enhanced the sensitivity of cancer cells to chemotherapeutic agents.

Conclusions:

  • NO production within lipid droplets is closely associated with acquired resistance to anti-tumor drugs.
  • Targeting NO in lipid droplets presents a potential therapeutic strategy to overcome chemoresistance.
  • The developed TAN probe is a valuable tool for studying NO-related biological processes in deep cellular compartments.

Related Concept Videos